About Diosynth Biotechnology

Diosynth Biotechnology, a part of Schering-Plough Corporation, is a global Contract Manufacturing Organization (CMO) specializing in current Good Manufacturing Practices (cGMP) Biopharmaceutical production. The company serves its customers by applying a full set of capabilities that range from cell line development to clinical and commercial manufacturing of both fermentation and cell culture derived drug substance.  In its role as a CMO, Diosynth Biotechnology has produced recombinant proteins for both clinical and commercial projects and provided a critical role as a strategic Chemistry and Manufacturing Controls (CMC) partner for many developers of biological therapeutics. 

 

Diosynth Biotechnology’s mission is to be the preferred and most trusted CMO in the biotech industry due to its technical excellence, reliable execution and collaborative approach in partnership with its customers.  The company’s goal is and has always been to help its customers succeed in what matters most…ultimately delivering the drug to the patient. Through Diosynth Biotechnology’s support in CMC development, biotechnology companies have been assured of dedicated manufacturing services that meet industry requirements in speed, quality and yield.

 

Diosynth Biotechnology has an 80-year heritage in biologics manufacturing and is a global leader in technology-driven process development and cGMP manufacturing of recombinant proteins, monoclonal antibodies and peptides. The company helps its customers succeed by developing scalable and robust processes and by driving products efficiently, rapidly and cost-effectively from preclinical development to market supply. Diosynth Biotechnology serves pharmaceutical and biopharmaceutical customers globally and operates FDA-, Health Canada- and EMEA-inspected cGMP manufacturing facilities in Research Triangle Park, NC USA, and Oss, the Netherlands.

For more information visit:  www.diosynthbiotechnology.com